211 related articles for article (PubMed ID: 19431954)
41. Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists.
Daïkha-Dahmane F; Levy-Beff E; Jugie M; Lenclen R
Pediatr Nephrol; 2006 May; 21(5):729-32. PubMed ID: 16565869
[TBL] [Abstract][Full Text] [Related]
42. Olmesartan: sprue-like enteropathy.
Prescrire Int; 2016 May; 25(171):130-1. PubMed ID: 27280200
[TBL] [Abstract][Full Text] [Related]
43. [Therapeutic experiences with Nortensin in the therapy of hypertension due to pregnancy].
Franck H; Gruhl M
MMW Munch Med Wochenschr; 1974 Mar; 116(10):521-4. PubMed ID: 4206421
[No Abstract] [Full Text] [Related]
44. [Fetal toxicity of angiotensin-II receptor antagonists].
Payen V; Chemin A; Jonville-Béra AP; Saliba E; Cantagrel S
J Gynecol Obstet Biol Reprod (Paris); 2006 Nov; 35(7):729-31. PubMed ID: 17088776
[TBL] [Abstract][Full Text] [Related]
45. Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation.
Sugihara M; Miura S; Takamiya Y; Kiya Y; Arimura T; Iwata A; Kawamura A; Nishikawa H; Uehara Y; Saku K
Hypertens Res; 2009 Jul; 32(7):625-30. PubMed ID: 19461652
[TBL] [Abstract][Full Text] [Related]
46. Olmesartan-associated severe gastritis and enteropathy.
Shenbagaraj L; Swift G
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567227
[TBL] [Abstract][Full Text] [Related]
47. Olmesartan: sprue-like enteropathy.
Prescrire Int; 2014 Apr; 23(148):102. PubMed ID: 24860900
[TBL] [Abstract][Full Text] [Related]
48. [Use of beta blockers (propranolol) in the treatment of arterial hypertension during pregnancy].
Tcherdakoff P; Kreft C
Acquis Med Recent; 1977; ():207-16. PubMed ID: 910599
[No Abstract] [Full Text] [Related]
49. Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort study.
Hoeltzenbein M; Tissen-Diabaté T; Fietz AK; Zinke S; Kayser A; Meister R; Weber-Schoendorfer C; Schaefer C
Clin Res Cardiol; 2018 Aug; 107(8):679-687. PubMed ID: 29574489
[TBL] [Abstract][Full Text] [Related]
50. Prenatal maternal indomethacin use resulting in prolonged neonatal renal insufficiency.
Gloor JM; Muchant DG; Norling LL
J Perinatol; 1993; 13(6):425-7. PubMed ID: 8308583
[TBL] [Abstract][Full Text] [Related]
51. Severe spruelike enteropathy associated with olmesartan observed by double-balloon enteroscopy.
Fukushima M; Kitamoto H; Inokuma T; Imai Y
Gastrointest Endosc; 2016 Jan; 83(1):269-70. PubMed ID: 26149710
[No Abstract] [Full Text] [Related]
52. Olmesartan associated enteropathy. A multiface clinical and histological entity.
Del Sordo R; Riccardi L; Engel PJH; Villanacci V
Dig Liver Dis; 2021 May; 53(5):666-668. PubMed ID: 33744171
[No Abstract] [Full Text] [Related]
53. [Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations].
Lonati C; Morganti A
Pediatr Med Chir; 2009; 31(3):137-9. PubMed ID: 19739495
[No Abstract] [Full Text] [Related]
54. Olmesartan-associated sprue-like enteropathy.
Stanich PP; Yearsley M; Meyer MM
J Clin Gastroenterol; 2013; 47(10):894-5. PubMed ID: 23751857
[No Abstract] [Full Text] [Related]
55. Liver injury related to olmesartan-associated sprue-like enteropathy.
Kogachi S; Treyzon L; Waters K; Sundaram V
Liver Int; 2019 Nov; 39(11):2204. PubMed ID: 31423708
[No Abstract] [Full Text] [Related]
56. Use of olmesartan for ≥ 1 year was associated with hospitalization for intestinal malabsorption.
Talley NJ
Ann Intern Med; 2015 Dec; 163(12):JC13. PubMed ID: 26666803
[No Abstract] [Full Text] [Related]
57. Reversible fetal renal failure after maternal treatment with Candesartan: a case report.
Munk PS; von Brandis P; Larsen AI
Reprod Toxicol; 2010 Jun; 29(3):381-2. PubMed ID: 20132879
[TBL] [Abstract][Full Text] [Related]
58. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
59. [Acute renal failure induced by angiotensin II receptor blocker in a patient with horseshoe kidney].
Kusaba K; Kameo H; Nagata N; Nagano M; Iwahashi M; Tamaki K
Nihon Naika Gakkai Zasshi; 2007 Jun; 96(6):1195-8. PubMed ID: 17607995
[No Abstract] [Full Text] [Related]
60. Angiotensin-converting enzyme inhibitors in pregnancy may result in neonatal renal failure.
Hulton SA; Thomson PD; Cooper PA; Rothberg AD
S Afr Med J; 1990 Dec; 78(11):673-6. PubMed ID: 2251614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
